Updated: 24 November 2025

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

24 November 2025

111

Must Read

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

Source link

Premier League highlights: Manchester United 0-1 Everton

Bitcoin miners squeezed by record hashrate even as sector stocks jump

- Advertisement -

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

- Advertisement -

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

LEAVE A REPLY Cancel reply

Wear This ’90s-Coded Outfit If You Want to Look Chic This Fall

Stripe Is Finalizing $8B OpenRouter Purchase, Investors Could Gain

Chocó, Colombia, Faces Deeper Hardship After an Earthquake

Bitcoin catches a bid after weekly loss, on track for best day in over a month

Solar Team Eindhoven unveils solar-powered mobile clinic Stella Juva

More Articles Like This

Category

Links

Stay connected

Mail us : thetimes365@thetimes365.com

Newsletter Signup